The cysteine proteinase cathepsin B has been implicated in tumor progression by virtue of its increased mRNA and protein levels, as well as its localization at the invading front of the tumor. In this study, we examined whether blocking cathepsin B expression in human glioblastoma SNB19 cells affects angiogenesis. Stable transfectants of human glioblastoma cells with a plasmid containing antisense cathepsin B cDNA showed decreased migration rates in wound-and spheroid-migration assays. Analysis showed a reduction in VEGF protein and MMP-9 activity in the cathepsin B antisense cDNA-transfected cells. Regarding angiogenesis in vitro, we found that the conditioned medium of glioblastoma cells with downregulated cathepsin B expression reduced cell-cell interaction of human microvascular endothelial cells, resulting in the disruption of capillary-like network formation. Furthermore, a marked reduction in microvasculature development was seen in an in vivo dorsal air sac assay of glioblastoma cells with downregulated cathepsin B expression. Taken together, these results provide evidence that inhibition of cathepsin B expression can suppress glioblastoma-induced neovascularization.
Introduction
Gliomas are the most common of brain neoplasms and exhibit a high degree of diffuse local invasion of normal nervous tissue. Tumor cells often infiltrate beyond any obviously defined tumor margin and contribute to the high incidence of recurrence. Both primary and metastatic CNS tumors depend on angiogenesis; primary malignant brain tumors are among those human neoplasms that exhibit the greatest angiogenic activity (Lopes, 2003) . The degree of neovascularization in these tumors has a strong impact on the tumor grade classification as well as prognosis establishment (Wesseling et al., 1997) .
The lysosomal cysteine proteinase cathepsin B is one of the multiple proteinases that have been linked to tumor progression through observations of activity, secretion and membrane association Sameni et al., 1995) . Cathepsin B levels are elevated in malignant tumors, particularly at the invasive edge of the tumor. The increased expression of cathepsin B mRNA has been reported in several human tumors including brain, colon, lung, prostate and esophageal adenocarcinoma (Spiess et al., 1994; Mikkelsen et al., 1995; Iacobuzio-Donahue et al., 1997; Hizel et al., 1998; Hughes et al., 1998) . In addition, an increased abundance of cathepsin B transcripts and protein in tumor tissues correlates with clinical invasive features (Iacobuzio-Donahue et al., 1997; Hizel et al., 1998) . Reports have indicated that cathepsin B expression is higher in brain tumors (Demchik et al., 1999) , suggesting that cathepsin B may be involved in tumor invasiveness and angiogenesis (Strojnik et al., 1999) . Moreover, cathepsin B not only structurally affects the basement membrane and degrades extracellular matrix (ECM) components such as laminin, collagen and fibronectin, but also activates other proteolytic enzyme systems (Kobayashi et al., 1991; Buck et al., 1992; Guinec et al., 1993; Creemers et al., 1998) . Our interest in gliomas led us to consider the role of cathepsin B in glioma angiogenesis. Here, we studied the effects of inhibition of cathepsin B expression in human glioblastoma cells on angiogenesis in in vitro and in vivo models.
Results

Downregulation. of cathepsin B and inhibition of cell migration
Antisense cathepsin cDNA containing an expression vector transfected in human glioblastoma SNB19 cells resulted in reduced cathepsin B mRNA, protein and enzyme activity (Mohanam et al., 2001) . Since cathepsin B has been implicated in the invasiveness of tumor cells including glioblastoma cells, we evaluated the migration of parental and stable transfectants in terms of the ability to traverse membranes coated with type I collagen in transwell inserts. The migration of cathepsin B stable transfectants decreased significantly as compared with parental and vector transfectants ( Figure  1a, b) . Scrape-wound-migration and three-dimensional spheroid-migration assays were also performed to address the migratory functions altered by downregulation of cathepsin B. In a wound-induced migration assay, the subconfluent cell monolayer was disrupted and cells were allowed to migrate into the cell-free area. The mobility of transfectants was decreased in the scrape-wound assay, as compared with vector control and parental cells (Figure 1c, d) . Finally, to further confirm the involvement of cathepsin B in cell migration, we assessed cell migration from spheroids. Both the parental-and empty vector-transfected cells have a uniform area of cells that moved away from the spheroids, whereas the cathepsin B antisense stable transfectants had a significantly smaller area of migrating cells (Figure 1e, f) .
Downregulation of cathepsin B and proangiogenic molecules
The effect of cathepsin B downregulation was examined on proangiogenic molecules including MMP-9 and VEGF in the cathepsin B antisense-transfected SNB19 cells. Since MMP-9 and VEGF are associated with glialinduced angiogenesis, their levels were measured in parental and transfected cells. Under normal conditions, SNB19 cells exhibited abundant MMP-2 with undetectable levels of MMP-9. To detect MMP-9, gelatinolytic activities of culture supernatants of parental and cathepsin B stable transfectants treated with and without PMA were determined by gelatin zymography. Figure 2 shows that treatment of SNB19 parental-and empty vector-transfected cells with PMA resulted in the release of MMP-9, which is normally undetectable in this cell line. However, cathepsin B antisense transfectants failed to exhibit MMP-9 activity in the presence of PMA, suggesting that suppression of cathepsin B results in blocking MMP-9 activity. To examine which signaling pathway(s) may be involved in MMP-9 induction and the requirement activation of each pathway in PMA-mediated MMP-9 upregulation, we utilized chemical inhibitors of the ERK and PI3K signaling Figure 2 Inhibition of MMP-9 by antisense cathepsin B transfection in human glioblastoma cells. SNB19 parental and transfected cells were treated with and without 10 mM PMA. Serum-free conditioned medium was collected after 24 h and MMP activity was determined using gelatin zymography. SNB19 cells were also treated with PD98059 and LY294002 in the presence of PMA. This is a representative experiment of three with similar results Cathepsin B and angiogenesis in glioma N Yanamandra et al pathways. PD098059 is known to selectively block the activity of MAP kinase (MEK), an activator of ERK kinases, and LY294002 inhibits PI3-K activity. The induction of MMP-9 in SNB19 cells treated with PMA was suppressed by PD98059 (MEK1 inhibitor) and LY294002 (PI3K inhibitor), and the involvement of cathepsin B effect on MMP-9 through these signaling cascades to be investigated.
The results presented above suggested to us that cathepsin B could indirectly affect tumor-cell-mediated angiogenesis, perhaps by modulating the production of endogenous angiogenic factors such as VEGF. The expression of VEGF in cathepsin B stable antisense transfectants was further determined at the protein level. Downregulation of cathepsin B by antisense transfection in SNB19 cells resulted in a reduction of VEGF protein secreted into media by antisense tumor cells compared with empty vector-transfected cells, as determined by quantitative VEGF ELISA (Figure 3) . Quantization of the data showed 45-65% suppression of endogenous VEGF production in all antisense tumor cells. These results suggest that, in addition to MMP-9, cathepsin B may regulate VEGF expression at the protein level.
Cathepsin B inhibition and angiogenesis
The reduction in proangiogenic molecules in cathepsin B antisense transfectants prompted us to examine the angiogenic potential of these cells. The effect of cathepsin B downregulation on angiogenesis was determined both in vitro and in vivo. To study the influence of secretory factors from glioblastoma cells on capillary-like structure formation in endothelial cells, conditioned medium from parental SNB19 and cathepsin B stable transfectants was added to HMECs and monitored for capillary-like structure formation. Conditioned medium from both parental SNB19 cells and empty vector transfectants influenced the formation of capillary-like structures in HMECs, whereas cathepsin B stable antisense transfectants failed to induce capillarylike structure formation (Figure 4a, b) .
Additionally, we examined the effect of cathepsin B downregulation in glioblastoma cells on capillary-like structure formation in coculture assays. Glioblastoma and endothelial cells were cocultured and the formation of capillary-like structures was observed by staining for the factor VIII antigen. HMECs cultured with SNB19 cells undergo alignment into cords, whereas HMECs grown with cathepsin B antisense transfectants showed no capillary formation. The results clearly show that the To confirm in vitro findings, we examined whether suppression of cathepsin B expression could inhibit tumor angiogenesis in an experimental model system assessed by a dorsal air sac assay in vivo. Implantation of a chamber containing SNB19 cells resulted in the development of microvessels (as indicated) with curled thin structures, and many tiny bleeding spots in addition to the pre-existing vessels ( Figure 5 ). However, a marked reduction in the development of such tumor cell-induced microvasculatures was observed in the cathepsin B-downregulated glioblastoma cells.
Discussion
Since cathepsin B has been linked to the increased capacity of human and rodent tumors to invade and metastasize (Nakao et al., 1989; Demchik et al., 1999; Lorenzo et al., 2000) , we investigated whether cathepsin B is also involved in the angiogenic process of human glioblastomas. The results here demonstrate that suppression of cathepsin B expression in human glioblastoma cells by cathepsin B antisense transfection reduces cell migration and angiogenic potential. The antisense vector transfection-mediated downregulation of cathepsin B was associated with inhibition of MMP-9 activity and reduced VEGF protein in culture supernatants. Reduced MMP-9 activity and VEGF protein correlated with decreased capillary-like structure formation in in vitro studies and reduced angiogenesis in the dorsal air sac assay (in vivo). Our results therefore provide direct evidence for the involvement of cathepsin B in the regulation of angiogenesis in glioblastoma cells.
Cell migration is a highly regulated process, which is critical for physiologic and pathologic tissue remodeling. Cathepsin B is capable of degrading specific ECM components (Buck et al., 1992) and activating extracellular proteinases such as soluble and receptor-bound pro-uPA (Kobayashi et al., 1993) . Recent studies using molecular genetic techniques to manipulate cathepsin B levels in established tumor cell lines have shown conflicting results for the contributions of cysteine proteinase B to cell motility. The motility of murine squamous carcinoma cells was unaffected by stable transfection of human cathepsin B cDNA, in spite of a threefold increase in the level of secreted pro-cathepsin B (Coulibaly et al., 1999) . Decreasing cathepsin B activity by cathepsin B antisense expression plasmid was found to have no effect on the motility of human melanoma (A375M) and prostate carcinoma (PC3M) cells (Szpaderska and Frankfater, 2001 ). In contrast and more similar to our results, stable transfection of human cathepsin B antisense cDNA into a human osteosarcoma cell line resulted in a 20-29% decrease in motility (Krueger et al., 1999) . As these various studies indicate, the mechanisms responsible for the influence of cathepsin B on tumor cell motility require further examination.
Angiogenesis plays a critical part in tumor development and progression, as it is the process by which a tumor increases its supporting vascular supply. Numerous angiogenic factors that regulate this complex process alone or in synergy have been identified (Liekens et al., 2001 ). The development of new blood vessels in tumors depends on the production of angiogenic factors released from the tumor cells and/or stromal cells. VEGF and MMP-9 have been shown to be involved in angiogenesis in a variety of experimental models (Vu et al., 1998; Miyoshi and Ohshima, 2001; Hamano et al., 2003; Virgintino et al., 2003) . However, the mechanisms that regulate the expression of angiogenic factors in tumor cells are still not well understood. The survival and growth of tumor cells are dependent on angiogenesis, which is further indicated by the fact that solid tumors cannot grow beyond 1-2 mm in diameter. The progressive growth of glioblastomas is angiogenesisdependent. Glioblastoma cells can secrete a variety of proangiogenic molecules including VEGF and type IV collagenases (Machein and Plate, 2000) . Expression of VEGF by glioblastoma cells has been shown to directly Figure 5 Tumor angiogenesis in vivo. To study the role of cathepsin B on angiogenesis in human glioblastoma cells, we examined parental SNB19 cells and cathepsin B stable antisense transfectants using the dorsal air sac assay. Subcutaneous implantation of a chamber containing tumor cells in nude mice results in the development of microvessels (as indicated by arrows) with curved thin structures and many tiny bleeding spots (magnification Â 70). Microvessel development was markedly less where the cathepsin B antisense transfectants had been implanted as compared with the controls. PV, pre-existing vessels; TN, tumor vessels Cathepsin B and angiogenesis in glioma N Yanamandra et al correlate with malignant potential (Chaudhry et al., 2001; Virgintino et al., 2003) and administration of anti-VEGF antibodies to mice injected with human glioblastoma cancer cells has been shown to inhibit neovascularization within the tumors (Kim et al., 1993) . Moreover, a mere threefold suppression of VEGF expression in GBM xenografts was capable of nearly obliterating the tumorigenic ability and vascularization of these malignant cells (Cheng et al., 1996) . It is therefore not surprising that we also found a profound suppression of angiogenesis in our in vitro capillary-like structure formation assays.
Gelatinase activity also appeared to be increased in malignant tissues as compared to low grade and normal brain tissue (Rao et al., 1993 (Rao et al., , 1996 Kachra et al., 1999) .
In this study, we demonstrated that an antisense cathepsin B cDNA expression plasmid was able to downregulate MMP-9 secretion in SNB19 cells. This suppression was specific for MMP-9, since cathepsin B suppression did not alter the secretion of MMP-2, another closely related gelatinase, under the same experimental conditions. This can generally be ascribed to cell-type specificity, as different cell lines may have different levels of signaling molecules and downstream transcription factors. We have also demonstrated that blockage of either ERK or PI3K activation could inhibit MMP-9 production. This study suggests that induction of MMP-9 by PMA may be dependent on the activation of more than one signaling pathway, namely the ERK and PI3K pathways. The chemical inhibitors that we used to block the function of these kinases are reported to be highly specific and caused no apparent phenotypical changes in the cells during the assay.
Malignant cells have an expanded repertoire of growth-promoting factors that are required for endothelial cell proliferation and migration, and, hence, neovascularization of the tumor bed. In addition to growth factors, there are a number of tumor-derived molecules that affect angiogenesis. It has been shown that bovine aortic endothelial cells form capillary-like structures in collagen type I when cocultured with human glioma cells. The production of FGF-2 by the glioma cells correlates with this process (Abe et al., 1993) . Bovine retinal endothelial cells reorganize into thin capillary-like structures when cocultured with human glioblastoma cells (Chandrasekar et al., 2000; Nirmala et al., 2000) . Telomerase-immortalized human microvascular endothelial cells undergo tubule formation when cocultured in the presence of human glioma cells, but not primary human astrocytes (Venetsanakos et al., 2002) . Thus, tumor cells appear to control the differentiation of endothelial cells during tumor-induced angiogenesis. These data suggest that specific cellular interactions between endothelial cells and glioma cells may influence the release of autocrine/paracrine endothelial growth and differentiation factors to promote capillary-like structure formation. Other investigators have also examined endothelial cell differentiation into capillary-like structures in response to the conditioned media of different tumors. Conditioned media from highly metastatic tumor cell lines such as murine melanoma B16F10 induced the formation of capillarylike structures in bovine aortic endothelial cells plated onto Matrigel (Garrido et al., 1995) . In our studies, we used both cocultures and tumor cell-conditioned media. We found that cathepsin B-downregulated human glioblastoma cells and their conditioned media inhibited capillary-like structure formation. These results provide direct evidence for the role of cathepsin B in the regulation of tumor angiogenesis in human glioblastoma cells.
In conclusion, our data demonstrate that cathepsin B regulates MMP release and VEGF protein. The results indicate a novel mechanism of action in that the increase of cathepsin B may contribute to human GBM progression through regulation of angiogenesis. Therefore, overexpression of cathepsin B contributes to tumor progression through multiple mechanisms. We propose that cathepsin B is a worthwhile therapeutic target for cancer, since this protease is implicated in many areas of tumor progression including angiogenesis and invasion.
Materials and methods
Chemicals and reagents
PD98059 and LY294002 were purchased from Promega (Madison, WI, USA). The VEGF ELISA kit was purchased from Pierce Biotechnology (Rockford, IL, USA). Reagents for SDS-PAGE and polyacrylamide were obtained from Bio-Rad Laboratories (Hercules, CA, USA).
Cell culture
The human glioblastoma cell line SNB19 was maintained in DMEM/F12 medium supplemented with 10% FCS, in a humidified atmosphere containing 5% CO 2 at 371C. The human dermal microvascular endothelial cell line HMEC-1 was obtained from Francisco J Candal (Centers for Disease Control and Prevention, Atlanta, GA, USA). HMEC-1 cells were grown in MCDB-131 supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ ml streptomycin, 5 ng/ml epidermal growth factor (BD Biosciences, Bedford, MA, USA) and 1 mg/ml hydrocortisone (Sigma, St Louis, MO, USA) at 371C with 5% CO 2 .
Preparation of constructs and transfection
A 1.15-kb cDNA fragment coding for cathepsin B (Cao et al., 1994) was blunt end cloned in the antisense orientation into the HindIII site of the eukaryotic expression vector pH-b-Aprneo-1 (Gunning et al., 1987) . Stable antisense transfectants were generated and characterized as described earlier (Mohanam et al., 2001) .
Cell motility assay
Cellular motility was evaluated using 24-well transwell chambers with 8-mm polycarbonate membrane filters separating the upper and lower culture compartments. Cells were harvested, suspended in serum-free medium and aliquoted at 2 Â 10 5 cells/well onto the filters, which had previously been coated with type I collagen. After a 24 h incubation period, the filters were removed and the nonmigrating cells in the top wells were removed. The migrating cells remaining on the bottom part of the filters were fixed and stained with Hema-3. Cells were counted and expressed as a percentage of parental cells migrated through the membranes.
Wound-induced migration assay
Migration through a wound introduced in a cell monolayer was assayed as described elsewhere (Chandrasekar et al., 2003) . Briefly, 2 Â 10 5 cells suspended in DMEM/F12 with 10% FCS were plated onto 12-well culture plates and incubated for 24 h. Then, a single wound was created in the center of the cell monolayer by the gentle removal of the attached cells with a sterile plastic pipette tip, debris was removed with two washings with PBS and the medium was replaced. After 24 h, the distance that the advancing cells had moved into the cell-free (wound) area was measured, after which the cells were fixed and stained with Hema-3 and photographed as described earlier. The scraped area was observed and photographed using an inverted photomicroscope (Olympus). Cell migration from the border of the wounded area was measured in separate fields using Image-Pro Discovery program (Media Cybernetics, Silver Spring, MD, USA) for the parental, vector control and cathepsin B antisense cells.
Cell migration from spheroids
Migration from spheroids was assayed by a previous method (Mohanam et al., 1997) modified as follows. Multicellular glioma spheroids were prepared by seeding a suspension of 3 Â 10 6 cells in DMEM/F12 onto 35-mm tissue culture dishes coated with 0.75% Noble agar. Cells were cultured until spheroids formed and single spheroids were placed in the center of each well of a 96-well microplate. Spheroids were cultured for 24 h, after which the spheroids were fixed and stained with Hema-3. Cellular migration from the spheroids was assessed under light microscopy.
Gelatin zymography
To determine the effect of cathepsin B antisense transfection on PMA-induced MMP-9 activity, parental and transfected cells were treated with PMA (100 nM) and MMP-9 expression was evaluated using zymography. SNB19 cells were also treated with PD90859 (50 mM) and LY294002 (10 mM) and PMA-induced MMP-9 activity was measured. Zymography was performed by a procedure described earlier (Rao et al., 1993) . Cells were grown until B80% confluent, the medium was removed and then fresh serum-free medium was added with and without PMA. Supernatants were collected after a 24 h incubation period. Proteins were subjected to SDS-PAGE in 10% polyacrylamide gels that were copolymerized with 1 mg/ml of gelatin. After electrophoresis, the gels were washed twice in 2.5% Triton X-100 for 30 min at room temperature to remove the SDS, then incubated overnight at 371C in Tris-HCl buffer (50 mM) containing 10 mM CaCl 2 . The gels were stained with Coomassie blue and then destained in a solution of acetic acid and methanol. The proteolytic activity was visualized as clear bands against a blue background of stained gelatin. Serum-free conditioned medium from HT1080 cells was used to identify the gelatinolytic bands and their approximate weights on the gels.
ELISA analysis of VEGF release
Cells were cultured in six-well culture plates until near confluence. The spent medium was removed, dishes washed three times and incubated with serum-free medium for 24 h.
The conditioned medium was stored at À801C and VEGF concentration was determined using an ELISA kit, as per the manufacturer's instructions.
Capillary-like structure formation
In all, 1 Â 10 5 human microvascular endothelial cells were seeded onto 48-well plates and grown in the presence of serumfree conditioned medium collected from SNB19 parental and transfected cells for 48 h. Cells were stained with Hema-3 and photographed. The total tube length was determined by computer-assisted image analysis with the Image-Pro Discovery program.
Capillary-like structures in cocultures 2 Â 10 4 SNB19 cells were plated onto tissue culture chamber slides. After an overnight incubation, the medium was removed and 4 Â 10 4 human microvascular endothelial cells were added. After 2 days, the cultures were probed with factor VIII antibody and then FITC-conjugated secondary antibody. The rearrangement of endothelial cells into capillary-like structures in cocultures was photographed using fluorescence microscopy, as described elsewhere (Chandrasekar et al., 2000) .
Mouse dorsal air sac assay
The mouse dorsal air sac assay was used to evaluate the angiogenic response suppressed by antisense inhibition of cathepsin B in human glioblastoma SNB19 cells. The chamber consisting of a ring (Millipore, Bedford, MA, USA) covered with Millipore filters (0.45-mm pore size) on both sides was injected with 150 ml (1Â 10 6 cells) of cell suspension and implanted subcutaneously into an air sac formed previously in the dorsum of a nude mice via injection of an appropriate volume of air. On day 7, the implanted chambers were removed from the s.c.fascia of the treated animals. The angiogenic response was assessed under a stereomicroscope (Olympus Optical, Tokyo, Japan) by determination of the number of newly formed blood vessels 43 mm with the characteristic zigzagging pattern of tumor cell-induced new vasculature in the s.c. side of the skin area.
Statistical analyses
Student's t-test was carried out for comparison of paired mean experimental values.
Abbreviations CNS, central nervous system; ECM, extracellular matrix; ERK, extracellular signal-regulated kinase; FGF, fibroblast growth factor; HMEC, human microvascular endothelial cells; MMP, matrix metalloproteinase; PI3K, phosphatidylinositol-3-kinase; PMA, phorbol myristate acetate; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; VEGF, vascular endothelial growth factor.
